Clinical parameters fail to identify patients with myocardial viability on functional testing

Imran Aftidi, David S. Bach, Thomas H. Marwick, Jae Kuen Oh, Julio A. Panza, William A. Zoghbi

Research output: Contribution to journalArticle

Abstract

Detection of myocatdial viability is Important for management of patients with coronary artery disease (CAD) and ventricular dysfunction. Although viable myocardium can be accurately detected by additional tests, such as dobutamine echocardiography (DE), it is important to assess whether readily available clinical information can improve the selection of patients referred for viability testing. The purpose of this study was to determine if clinical findings predict the presence or absence of viability during DE. Data banks of participating institutions were searched from 1993 onward to identify patients with CAD and ventricular dysfunction that underwent DE. Patients were considered to have viable myocardium if at least 2 contiguous ventricular segments with abnormal wan motion (WM) at rest showed improvement in contractility during DE We studied 240 patients, 195 males, mean age 63±10 yrs. Viable myocardium was detected during DE in 175 (73%) patients. There was no difference in age between patients with and without viable myocardium (63±10 vs 63±10 yrs). Incidence of viable myocardium was 69% in females and 74% in males (p = NS). Incidence of viable myocardium in patients with and without different clinical characteristics is shown below: Clinical Characteristic Present Absent p value Chest pain 82*69*.05 Heart failure 74*73*.8 Prior infarction 73*72*.9 Beta blocter use 71*73*.3 Q wave on EKG 69*75*.3*% patients with viable myocardium by DE Baseline left ventricular ejection fraction was similar in patients with and without viable myocardium (26±6% vs 25±6%). Abnormal rest WM was present in 634 vascular regions. There was DO difference in percent vessel stenosis between regions with and without viability by DE (72±25% vs 71±28%, p = .2). Conclusions: Presence or absence of myocardial viability during DE cannot be determined from clinical data and requires additional testing.

Original languageEnglish (US)
Pages (from-to)393
Number of pages1
JournalJournal of the American Society of Echocardiography
Volume10
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Dobutamine
Echocardiography
Myocardium
Ventricular Dysfunction
Coronary Artery Disease
Incidence
Chest Pain
Stroke Volume
Infarction
Patient Selection
Blood Vessels
Electrocardiography
Pathologic Constriction
Heart Failure
Databases

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical parameters fail to identify patients with myocardial viability on functional testing. / Aftidi, Imran; Bach, David S.; Marwick, Thomas H.; Oh, Jae Kuen; Panza, Julio A.; Zoghbi, William A.

In: Journal of the American Society of Echocardiography, Vol. 10, No. 4, 1997, p. 393.

Research output: Contribution to journalArticle

Aftidi, Imran ; Bach, David S. ; Marwick, Thomas H. ; Oh, Jae Kuen ; Panza, Julio A. ; Zoghbi, William A. / Clinical parameters fail to identify patients with myocardial viability on functional testing. In: Journal of the American Society of Echocardiography. 1997 ; Vol. 10, No. 4. pp. 393.
@article{6f009704cc9f4e53b0829582d5d6a388,
title = "Clinical parameters fail to identify patients with myocardial viability on functional testing",
abstract = "Detection of myocatdial viability is Important for management of patients with coronary artery disease (CAD) and ventricular dysfunction. Although viable myocardium can be accurately detected by additional tests, such as dobutamine echocardiography (DE), it is important to assess whether readily available clinical information can improve the selection of patients referred for viability testing. The purpose of this study was to determine if clinical findings predict the presence or absence of viability during DE. Data banks of participating institutions were searched from 1993 onward to identify patients with CAD and ventricular dysfunction that underwent DE. Patients were considered to have viable myocardium if at least 2 contiguous ventricular segments with abnormal wan motion (WM) at rest showed improvement in contractility during DE We studied 240 patients, 195 males, mean age 63±10 yrs. Viable myocardium was detected during DE in 175 (73{\%}) patients. There was no difference in age between patients with and without viable myocardium (63±10 vs 63±10 yrs). Incidence of viable myocardium was 69{\%} in females and 74{\%} in males (p = NS). Incidence of viable myocardium in patients with and without different clinical characteristics is shown below: Clinical Characteristic Present Absent p value Chest pain 82*69*.05 Heart failure 74*73*.8 Prior infarction 73*72*.9 Beta blocter use 71*73*.3 Q wave on EKG 69*75*.3*{\%} patients with viable myocardium by DE Baseline left ventricular ejection fraction was similar in patients with and without viable myocardium (26±6{\%} vs 25±6{\%}). Abnormal rest WM was present in 634 vascular regions. There was DO difference in percent vessel stenosis between regions with and without viability by DE (72±25{\%} vs 71±28{\%}, p = .2). Conclusions: Presence or absence of myocardial viability during DE cannot be determined from clinical data and requires additional testing.",
author = "Imran Aftidi and Bach, {David S.} and Marwick, {Thomas H.} and Oh, {Jae Kuen} and Panza, {Julio A.} and Zoghbi, {William A.}",
year = "1997",
language = "English (US)",
volume = "10",
pages = "393",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical parameters fail to identify patients with myocardial viability on functional testing

AU - Aftidi, Imran

AU - Bach, David S.

AU - Marwick, Thomas H.

AU - Oh, Jae Kuen

AU - Panza, Julio A.

AU - Zoghbi, William A.

PY - 1997

Y1 - 1997

N2 - Detection of myocatdial viability is Important for management of patients with coronary artery disease (CAD) and ventricular dysfunction. Although viable myocardium can be accurately detected by additional tests, such as dobutamine echocardiography (DE), it is important to assess whether readily available clinical information can improve the selection of patients referred for viability testing. The purpose of this study was to determine if clinical findings predict the presence or absence of viability during DE. Data banks of participating institutions were searched from 1993 onward to identify patients with CAD and ventricular dysfunction that underwent DE. Patients were considered to have viable myocardium if at least 2 contiguous ventricular segments with abnormal wan motion (WM) at rest showed improvement in contractility during DE We studied 240 patients, 195 males, mean age 63±10 yrs. Viable myocardium was detected during DE in 175 (73%) patients. There was no difference in age between patients with and without viable myocardium (63±10 vs 63±10 yrs). Incidence of viable myocardium was 69% in females and 74% in males (p = NS). Incidence of viable myocardium in patients with and without different clinical characteristics is shown below: Clinical Characteristic Present Absent p value Chest pain 82*69*.05 Heart failure 74*73*.8 Prior infarction 73*72*.9 Beta blocter use 71*73*.3 Q wave on EKG 69*75*.3*% patients with viable myocardium by DE Baseline left ventricular ejection fraction was similar in patients with and without viable myocardium (26±6% vs 25±6%). Abnormal rest WM was present in 634 vascular regions. There was DO difference in percent vessel stenosis between regions with and without viability by DE (72±25% vs 71±28%, p = .2). Conclusions: Presence or absence of myocardial viability during DE cannot be determined from clinical data and requires additional testing.

AB - Detection of myocatdial viability is Important for management of patients with coronary artery disease (CAD) and ventricular dysfunction. Although viable myocardium can be accurately detected by additional tests, such as dobutamine echocardiography (DE), it is important to assess whether readily available clinical information can improve the selection of patients referred for viability testing. The purpose of this study was to determine if clinical findings predict the presence or absence of viability during DE. Data banks of participating institutions were searched from 1993 onward to identify patients with CAD and ventricular dysfunction that underwent DE. Patients were considered to have viable myocardium if at least 2 contiguous ventricular segments with abnormal wan motion (WM) at rest showed improvement in contractility during DE We studied 240 patients, 195 males, mean age 63±10 yrs. Viable myocardium was detected during DE in 175 (73%) patients. There was no difference in age between patients with and without viable myocardium (63±10 vs 63±10 yrs). Incidence of viable myocardium was 69% in females and 74% in males (p = NS). Incidence of viable myocardium in patients with and without different clinical characteristics is shown below: Clinical Characteristic Present Absent p value Chest pain 82*69*.05 Heart failure 74*73*.8 Prior infarction 73*72*.9 Beta blocter use 71*73*.3 Q wave on EKG 69*75*.3*% patients with viable myocardium by DE Baseline left ventricular ejection fraction was similar in patients with and without viable myocardium (26±6% vs 25±6%). Abnormal rest WM was present in 634 vascular regions. There was DO difference in percent vessel stenosis between regions with and without viability by DE (72±25% vs 71±28%, p = .2). Conclusions: Presence or absence of myocardial viability during DE cannot be determined from clinical data and requires additional testing.

UR - http://www.scopus.com/inward/record.url?scp=33748821399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748821399&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748821399

VL - 10

SP - 393

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 4

ER -